NCT02282215 2018-09-27Safety and Efficacy of Human Myeloid Progenitor Cells (CLT-008) During Chemotherapy for Acute Myeloid LeukemiaCellerant TherapeuticsPhase 2 Completed163 enrolled
NCT00430534 2007-02-02Evaluation of Safety, Immune-Response and Efficacy of GSK Biologicals' EBV (Epstein Barr Virus) Vaccine (268664).HenogenPhase 2 Completed200 enrolled